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Abstract 
 
Background: Interstitial lung diseases (ILD) refer to a group of diffuse parenchymal lung diseases 
classified together based on common radiographic, physiologic, or pathologic manifestations. Although 
there are many different classifications, the hallmark of ILD is fibrosis of alveolar walls, airways, and 
vasculature resulting in a restrictive lung disease. Some research supports the benefits of pulmonary 
rehabilitation for sub-acute treatment of ILD, but there is even less information regarding physical 
therapy interventions for acute exacerbations. Purpose: The purpose of this case report is to present 
interventions and outcomes for a patient with ILD in an intensive care (ICU) setting, as well as other 
considerations and interventions to consider with this patient population. Case Description: A 64 year-
old female was admitted to the ICU with hypoxic respiratory failure. The patient's past medical history 
was significant for ILD, systolic heart failure, severe pulmonary hypertension, coronary artery disease, 
oxygen dependence, obstructive sleep apnea, and hypothyroidism. Physical therapy interventions 
focused on increasing walking distance, with close monitoring of the patients vitals and respiratory 
status to ensure safety.  Outcome measures: The primary outcome measure used during the patient’s 
hospital stay was walking distance, showing an improvement from 15 feet to 200 feet over 20 days. 
Discussion:  This case presents an acute plan of care for a patient with ILD in the ICU setting, 
addressing efficacy of exercise training in this patient population, and demonstrating success in 
improving walking distance in this patient case in preparation for discharge to sub-acute pulmonary 
rehabilitation. 
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Background 
 Interstitial lung diseases (ILDs) are a heterogeneous group of diseases that affect the 
parenchyma of the lung. The parenchyma includes the alveoli, alveolar epithelium, the capillary 
endothelium, and space between these structures. As a group, they are classified together based on 
similar clinical, pathophysiologic, and medical imaging manifestations. The term “interstitial” can be 
somewhat of a misnomer, as it refers to a common finding of interstitial opacities shown on a chest 
radiograph and the pathologic appearance that the disease first affects the interstitium. [1] However, 
most of the over 200 diseases classified as ILDs, have significant involvement of alveoli and airway 
architecture. ILDs are classified into two groups, ILDs of known cause and idiopathic ILDs. The most 
common known causes of ILDs are inhalation of occupational and environmental agents, most notably 
inorganic or organic dusts, pulmonary toxicity due to drug reaction, and radiation-induced lung injury. 
Various connective tissue diseases can also lead to ILD such as polymyositis/dermatomyositis, 
rheumatoid arthritis, systemic lupus erythematosus, and scleroderma. Accurate diagnosis is important 
because medical treatment of the disease will vary based on different types of the disease. Diagnosis 
usually requires a team of healthcare professionals 
working together. Regardless of classification, the hallmark 
of ILDs is irreversible fibrosis of the lung parenchyma. [2] 
Precise pathogenesis of ILD is poorly understood. 
A popular proposal involves damage to distal airspace 
tissue from environmental exposure, systemic disease, 
infection, or radiation. [3] Another similar proposal, seen in 
Figure 1, involves distal airspace tissue damage but 
suggests the body responds to this damage with abnormal 
wound healing, leading to fibrosis. [2] Fibrosis leads to 
many detrimental factors for these patients and can 
progress to a vicious cycle. Oxygen diffusion limitations 
and ventilation-perfusion mismatching occur as the 
pulmonary capillary bed is damaged. This leads to patients 
experiencing dyspnea on exertion, which can lead to 
decreased activity levels. Decreased activity levels lead to 
further physical deconditioning and more pronounced 
dyspnea on exertion. Pulmonary vasoconstriction may also 
result in pulmonary hypertension and possible cardiac 
dysfunction. [4] 
Figure 1. Pathogenesis of pulmonary fibrosis. 
Adapted from D.L. Kasper, A.S. Fauci, S.L. Hauser, D. 
L. Longo, L. Jameson.  
 
Medical treatments for ILD are limited, as the disease is progressive with no known cure. The 
main goal is typically to remove offending agents or inflammation that lead to lung tissue damage. High 
doses of corticosteroids and antibiotics are commonly prescribed even though there is little evidence to 
show efficacy of these treatments. [2] Long term use of corticosteroids may have negative impacts on 
muscle function [5]. Pulmonary fibrosis is largely irreversible so limiting the extent of damage is key for 
good prognosis. [4] However, recent studies have shown potential benefits of medications such as 
pirfenidone and nintedanib. These benefits include slower decline of forced vital capacity (FVC) and 
reduced mortality. [6] Supplemental oxygen is often prescribed for patients with advanced ILD who 
have resting hypoxemia, but lack of evidence has made it difficult to know if supplemental oxygen has 
resulted in clinically meaningful outcomes [7].  Ultimately, lung transplantation is often considered for 
patients with severe progression of the disease. [2] 
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Patients with ILD are prone to acute exacerbations which are associated significant morbidity 
and mortality. Patients often present to the clinic with severe hypoxemia and respiratory failure and 
require admission to the intensive care unit. [8] Hospitalization is important for medical management 
but may lead to further deconditioning. One study found during an acute hospitalization, that older 
adults spend approximately 83% of their stay in bed and 12% in a chair. This increase in inactivity can 
lead to declines in strength, muscle mass, and physical function [9]. Patients with ILD may be more 
susceptible to these declines as their endurance and exercise tolerance is already limited. Minimal 
research is available regarding most appropriate acute physical therapy interventions in this patient 
population. It may be difficult to work with these patients in an acute setting because their symptoms 
are most likely at their worst during this time. Yet, physical therapists have an opportunity to promote 
physical activity in this setting, which if tolerated, may lead to less deconditioning. This will potentially 
lead to a smoother transition from hospital care to home and outpatient pulmonary rehabilitation. Thus, 
the purpose of this case is to present an acute plan of care for a patient with ILD in the ICU setting and 
address potential outcomes of exercise training in this patient population. 
   
Case Description 
  
Presentation/History 
 
 A 65 year old female presented to pulmonary rehabilitation for a six minute walk test (6MWT) 
via motorized scooter. She reported severe shortness of breath (SOB) after using the bathroom, and 
transferring from the scooter to the toilet and back. Vitals were obtained revealing oxygen saturation 
(SpO2) of 69% for both forehead and finger probes, heart rate was 127 beats per minute, and systolic 
blood pressure was 82 mmHg via Doppler, as cuff blood pressure was difficult to hear. The patient was 
normally on 5 liters per minute (LPM) of supplemental oxygen at baseline. This was increased to 6 LPM 
via high flow nasal cannula and then to 8 LPM to improve SpO2 to the low 90's at rest and mid 80's 
when the patient talked. A pulmonologist was notified and the patient was agreeable to be admitted to 
the ICU for further monitoring of acute hypoxic respiratory failure. 
 In the ICU, the patient required 10 LPM of oxygen at rest to maintain adequate Oxygen 
saturation, but continued to desaturate with minimal activity such transferring to the bedside chair and 
talking. Computed tomography (CT) of the chest showed slight progression of ILD when compared to a 
chest CT from two years prior. A ventilation and perfusion (V/Q) scan showed a positive mismatch, 
indicating possible pulmonary embolism (PE). Computed tomography angiography (CTA) ruled out a 
PE, so V/Q mismatching was postulated to be secondary to pulmonary fibrosis. An echocardiogram 
revealed right to left atrial shunting and right ventricular enlargement. A right heart catheterization was 
performed and showed significant pulmonary hypertension. Sildenafil and diuretics were started to help 
manage her pulmonary hypertension. Ambrisentan was started two days after sildenafil for optimum 
pulmonary hypertension management. 
The patient’s past medical history was significant for ILD of unknown cause, oxygen 
dependence, systolic heart failure, morbid obesity, severe pulmonary hypertension, obstructive sleep 
apnea, coronary artery disease, and cerebral vascular accident (CVA) in 1997.  
Previous pulmonary function tests (PFT’s) collected 5 months prior to hospitalization are 
provided in Table 1. Her PFT’s reveal typical findings for a patient with ILD. [2]   
The patient reported living with her husband in a multi-story home. She was able to stay  
on the main floor and didn’t have to go up steps to get into her home. Her pre-admission level of 
function was walking very short distances in her home only. She reported no use of assistive device for 
ambulation and utilized a motorized scooter when going outside the home. The patient reported being 
able to walk very short distances before becoming short of breath (SOB). 
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Table 1. Pulmonary function test data collected 5 months prior to hospitalization. 
 Measured Value 
(liters) 
Predicted value 
(liters) 
Percent of predicted 
value 
FVC .96 1.99 48 
FEV1 .96 1.54 62 
TLC Not measured 3.87  
(FVC) forced vital capacity, (FEV1) forced expiratory volume in 1 minuet, (TLC) total lung capacity 
 
Evaluation 
 
 A physical therapy evaluation was performed on the second day of the patient’s hospital 
admission. Her vitals were stable on 10 LPM of oxygen with SpO2 reading at 96%. Her gross range of 
motion was within functional limits bilaterally. The patient demonstrated mild weakness with upper 
extremity and lower extremity strength testing. Diminished breath sounds were heard with auscultation 
of the lungs. Lung examination is often abnormal in patients with ILD but findings vary and are usually 
nonspecific. Crackles are commonly heard and may be present only in lung bases in early stages of the 
disease. It may be helpful to auscultate the lung bases in the posterior axillary line [1]. Breathing rate 
was increased with shallow breaths consistent with reports from the literature indicating patients with 
pulmonary fibrosis exhibit rapid and shallow breathing with low values of tidal volume and very high 
breathing frequencies. [10] The patient was independent with bed mobility and only required standby 
assistance with transfers and ambulation. Assessing the patient’s gait revealed slow gait speed but no 
significant gait deviations. The patient demonstrated significant cardiovascular deconditioning. She was 
able to walk a distance of 10 feet before requiring a seated rest break due to SOB rated at 5/10 and 
fatigue. Careful planning was required to manage ICU equipment and supplemental oxygen to ensure 
the safety of our patient. “6-Clicks” basic mobility screening was calculated to be 19. This mobility 
screen is a short form adapted from researchers at Boston University. The form reports how much 
assistance the patient needs for six basic mobility questions. Higher scores indicate higher mobility with 
minimum score of 6 and a max score of 24. [11] 
 
Clinical Impression 
 
The patient would benefit from physical therapy to improve walking distance and conditioning 
with safe monitoring of vitals and oxygen requirements. The goal was to maintain aerobic endurance in 
order to return home and attend outpatient pulmonary rehabilitation.  
 
Interventions 
 
 The patient was seen by multiple physical therapists at a frequency of 4-6 times per week over 
her three week period of hospitalization. Interventions focused on keeping the patient as active as 
possible to minimize physical deconditioning while hospitalized.  
Several treatments were used with input based on clinical judgement of a senior therapist with 
extensive experience working with pulmonary patients.  However, ambulation was our main intervention. 
Initially, the patient was very limited in her ability to ambulate even short distances. Her SpO2 would 
drop to the mid 80’s and she would complain of SOB. After the initial evaluation, a front-wheeled walker 
was used to promote conservation of energy. Progress with walking distance was slow and hindered by 
continuous oxygen desaturations and SOB with exertion. We also incorporated various treatment 
strategies throughout the plan of care. We implemented interval walking to avoid extensive desaturation 
and feeling of SOB. 
The patient was unwilling to ambulate at times during her first week of hospitalization because 
she felt tired and was scared of making her symptoms worse. When this occurred, she performed 
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Theraband ® resistance exercises in bed, targeting both upper extremity and lower extremity muscles 
groups.  
The patient was educated on breathing strategies to optimize her available lung function. We 
recommended avoiding slow, deep breathes during ambulation because fibrotic lungs exhibit 
decreased compliance and will require more force to expand, resulting in increased work of breathing. 
Increased work of breathing results in respiratory muscles requiring a larger portion of total metabolic 
energy available. It is possible this leads to less total energy available to fuel muscles associated with 
ambulation. [10] Instead, we recommended breathing a comfortable pace, avoiding deep breaths, to 
halt significant energy expenditure of respiratory muscles. This may seem counterintuitive because 
increased respiratory rate leads to increased dead space ventilation. However, we postulated 
conserving energy during ambulation was more important. Working on deep breathing and expansion 
of lungs at rest may be more appropriate for this patient population. We also educated our patient to be 
cognizant of when her symptoms begin and to monitor her breathing frequency as a possible indicator 
of desaturation events. 
Nine days after admission, the patient was medically stable and transferred to a step down unit. 
We continued working on progressing with walking distance until discharge. 
  
Outcomes 
 
 Over the course of the patient’s three week hospitalization, including time in both the ICU and 
step down unit, the patient showed improvements in walking distance, required less supplemental 
oxygen at rest, and demonstrated an improved “6-Clicks” basic mobility score. Measured walking 
distance over the patient’s hospitalization can be seen in Table 2. At discharge, the patient was able to 
walk 200 ft, 190 feet further compared to admission, using a wheeled walker with several seated rest 
breaks but still required 15 LPM of oxygen to keep SpO2 above 90%. However, she was able to walk 
30 feet on 15 LPM before desaturation began. This is an improvement of 25 ft but with greater oxygen.  
Resting oxygen requirements had decreased to 8 LPM. Unfortunately, oxygen requirements at rest did 
not return to the patient’s baseline of 5 LPM.  The patient’s “6-clicks” mobility score improved from 19 to 
22, short of the minimal detectable change of 4.72. [12]  
 The patient was discharged home with in home physical therapy to continue her exercise 
progression. There was also a recommendation made to start outpatient pulmonary rehabilitation when 
able.  
 
Table 2. Progression of walking distance over course of hospitalization 
Day Walking distance (ft) 
1 (admission) 10  
4 50  
7 100  
18 (discharge) 200  
 
Discussion 
 
 Interstitial lung diseases are a group of disabling chronic lung conditions associated with 
interstitial inflammation and fibrosis of alveolar walls, airways, and vasculature resulting in a restrictive 
lung disease. [1,13] Patients often have reduced exercise capacity and SOB during exercise which can 
lead to decreased quality of life. [14]  
Acute exacerbations of the disease can occur at any time and often lead to hospitalization, as 
seen with the patient presented in this case. Frequency of exacerbations is unknown as reported 
incidence rates vary. Clinical presentation consists of rapid worsening of respiratory symptoms with 
increased dyspnea. [3] A significant secondary complication associated with ILD is pulmonary 
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hypertension. Pulmonary hypertension is prevalent in 30-40% of patients with ILD and is associated 
with high morbidity and mortality. [15] 
Medical treatments are limited and often demonstrate minimal impact on quality of life. Recent 
studies have led to conditional recommendations for using nintedanib and pirfenidone. Pooled analysis 
of three randomized control trials (RCT) showed fewer number of patients with more than 10% decline 
in FVC over a 12 month period when taking nintedanib compared to placebo (moderate confidence). 
However, concerns in regard to the high cost of this treatment may limit its availability. It’s also not 
reported whether this minimal decrease in progression of FVC decline would result in any clinically 
meaningful difference for these patients. Pirfendione is an oral antifibrotic drug shown to regulate 
important profibrotic and proinflammatory cytokine cascades in vitro while reducing fibroblast 
proliferation and collagen synthesis in animal models of lung fibrosis. Pooled results from 2 trials 
suggested reduced mortality (moderate confidence) and reduced rate of FVC decline  
(high confidence). [6] 
Pulmonary function testing is one tool to help assess the progression of pulmonary damage 
associated with ILD. As fibrosis becomes more widespread lung volumes and compliance decrease. 
This restrictive manifestation results in decreased lung volumes, which in turn leads to reduced forced 
expiratory volume in one minute (FEV1) and forced vital capacity (FVC). The FEV1/FVC ratio often is 
unaffected because there is no obstruction preventing air from being expired. Destruction of the 
alveolar capillary bed and reduced compliance of the lung may result in V/Q mismatching, as seen in 
the patient presented in this case. [2] 
Pulmonary rehabilitation for patients with obstructive lung diseases is well-established in the 
literature as improving exercise tolerance and reducing symptoms. Less evidence exists demonstrating 
similar effects for patients with ILD. Greater prevalence of exercise-induced hypoxia, pulmonary 
hypertension, and arrhythmia in this population compared to other chronic lung diseases warrants need 
for safe monitoring. Recent studies have shown exercise training to be safe for patients with ILD and 
demonstrate improvements in exercise tolerance, dyspnea, 6 minute walk distance, and quality of life 
after outpatient pulmonary rehabilitation. However, long-term benefits of pulmonary rehabilitation have 
yet to be demonstrated in the literature. This may be due to the progressive nature of the disease. [14] 
 There is a lack of evidence for acute physical therapy management of patients with ILD in the 
literature. Managing these patients in the ICU may present certain challenges not seen in other settings. 
Their baseline exercise capacity is often reduced and admittance to the ICU usually means they have 
other acute problems, likely leading to further reduced exercise capacity. Both the patient and other 
healthcare professionals, not familiar with physical therapists working with these patients, may have 
fear about making symptoms worse with physical activity. Managing that fear may consist of patient 
education and presenting the patient with alternative forms of exercise. Managing ICU equipment while 
working with critically ill patients can feel overwhelming, especially for a physical therapist with minimal 
experience in this setting. Planning ahead is crucial to ensure safety for the patient. The physical 
therapist must manage patient lines and supplemental oxygen, monitor the patient’s vitals, and have 
options for the patient to sit when a seated rest break is needed.  Assistance from nursing or other 
medical professionals may be required in some instances to ensure safety for these patients.  
 The patient in this case showed gradual improvement in her walking distance over the course of 
her hospitalization. We emphasized keeping the patient as mobile as possible, while safely monitoring 
her symptoms to avoid further exacerbation of her symptoms. She was able to tolerate some form of 
treatment on most days, which lead to her gradual improvement overall and eventual discharge home. 
She was also given a recommendation to attend outpatient pulmonary rehabilitation. This case 
supports the value of physical therapy in the ICU setting to promote safe exercise progression for 
patients with ILD. 
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